Teleflex Incorporated logo

Teleflex Incorporated (TBH)

Market Closed
12 Dec, 20:00
XSTU XSTU
107. 00
-2
-1.83%
- Market Cap
- P/E Ratio
0.54% Div Yield
0 Volume
- Eps
109
Previous Close
Day Range
107 107
Year Range
87.5 176
Want to track TBH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days

Summary

TBH closed today lower at €107, a decrease of 1.83% from yesterday's close, completing a monthly increase of 0.94% or €1. Over the past 12 months, TBH stock lost -36.69%.
TBH pays dividends to its shareholders, with the most recent payment made on Sep 15, 2025. The next announced payment will be in In 2 days on Dec 15, 2025 for a total of €0.34.
The last earnings report, released on Nov 06, 2025, missed the consensus estimates by -3.38%. On average, the company has fell short of earnings expectations by -1.13%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
Teleflex Incorporated has completed 5 stock splits, with the recent split occurring on Jun 17, 1997.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

TBH Chart

Teleflex: Selling, But How Much?

Teleflex: Selling, But How Much?

Teleflex Incorporated rebounded from lows after announcing a $2.03B divestiture of Acute Care, Interventional Urology, and OEM businesses. TFX will use $1B of net proceeds for share buybacks, reducing pro forma net debt to $1.5B, but revenue impact remains ambiguous. Shares now trade at 10x adjusted earnings, with market reaction positive despite uncertainty around divested revenue figures.

Seekingalpha | 2 days ago
Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Teleflex Incorporated ( TFX ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Liam Kelly - Chairman, President & CEO Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Great. Thanks for joining us here for our next session.

Seekingalpha | 3 weeks ago
Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock

Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock

Explore Teleflex's (TFX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks | 3 weeks ago

Teleflex Incorporated (TBH) FAQ

What is the stock price today?

The current price is €107.00.

On which exchange is it traded?

Teleflex Incorporated is listed on NYSE.

What is its stock symbol?

The ticker symbol is TBH.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.54%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 3.86.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Teleflex Incorporated ever had a stock split?

Teleflex Incorporated had 5 splits and the recent split was on Jun 17, 1997.

Teleflex Incorporated Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Liam J. Kelly CEO
XSTU Exchange
US8793691069 ISIN
US Country
14,100 Employees
14 Nov 2025 Last Dividend
17 Jun 1997 Last Split
18 Feb 1988 IPO Date

Overview

Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.

Products and Services

  • Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
  • Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
  • Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
  • Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
  • Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
  • Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
  • Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
  • Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.

Contact Information

Address: 550 East Swedesford Road
Phone: 610 225 6800